*Storage: Keep in dark place,Inert atmosphere,Room temperature.
*Shipping: Normal
4.5
*For Research Use Only !
Change View
Size | Price | USA Stock *0-1 Day | Global Stock *5-7 Days | In Stock |
250mg | łÇî¶ÊÊ | Inquiry | Inquiry | Login |
1g | łòǶÊÊ | Inquiry | Inquiry | Login |
5g | ł§ÊǶÊÊ | Inquiry | Inquiry | Login |
Please Login or Create an Account to: See VIP prices and availability
łÇî¶ÊÊ
łòǶÊÊ
ł§ÊǶÊÊ
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 100124-07-0 |
Formula : | C12H9BO3S |
M.W : | 244.07 |
SMILES Code : | OB(O)C1=C2OC3=CC=CC=C3SC2=CC=C1 |
MDL No. : | MFCD01605731 |
Boiling Point : | No data available |
InChI Key : | IIENVBUXFRSCLM-UHFFFAOYSA-N |
Pubchem ID : | 2734376 |
GHS Pictogram: | ![]() |
Signal Word: | Warning |
Hazard Statements: | H319-H315-H335 |
Precautionary Statements: | P261-P352-P280-P305+P351+P338 |
Num. heavy atoms | 17 |
Num. arom. heavy atoms | 12 |
Fraction Csp3 | 0.0 |
Num. rotatable bonds | 1 |
Num. H-bond acceptors | 3.0 |
Num. H-bond donors | 2.0 |
Molar Refractivity | 66.91 |
TPSA ? Topological Polar Surface Area: Calculated from | 74.99 Ų |
Log Po/w (iLOGP)? iLOGP: in-house physics-based method implemented from | 0.0 |
Log Po/w (XLOGP3)? XLOGP3: Atomistic and knowledge-based method calculated by | 2.5 |
Log Po/w (WLOGP)? WLOGP: Atomistic method implemented from | 1.62 |
Log Po/w (MLOGP)? MLOGP: Topological method implemented from | 1.68 |
Log Po/w (SILICOS-IT)? SILICOS-IT: Hybrid fragmental/topological method calculated by | 0.89 |
Consensus Log Po/w? Consensus Log Po/w: Average of all five predictions | 1.34 |
Log S (ESOL):? ESOL: Topological method implemented from | -3.38 |
Solubility | 0.101 mg/ml ; 0.000412 mol/l |
Class? Solubility class: Log S scale | Soluble |
Log S (Ali)? Ali: Topological method implemented from | -3.72 |
Solubility | 0.0465 mg/ml ; 0.00019 mol/l |
Class? Solubility class: Log S scale | Soluble |
Log S (SILICOS-IT)? SILICOS-IT: Fragmental method calculated by | -3.66 |
Solubility | 0.0539 mg/ml ; 0.000221 mol/l |
Class? Solubility class: Log S scale | Soluble |
GI absorption? Gatrointestinal absorption: according to the white of the BOILED-Egg | High |
BBB permeant? BBB permeation: according to the yolk of the BOILED-Egg | No |
P-gp substrate? P-glycoprotein substrate: SVM model built on 1033 molecules (training set) | Yes |
CYP1A2 inhibitor? Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set) | Yes |
CYP2C19 inhibitor? Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set) | No |
CYP2C9 inhibitor? Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set) | No |
CYP2D6 inhibitor? Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set) | No |
CYP3A4 inhibitor? Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set) | Yes |
Log Kp (skin permeation)? Skin permeation: QSPR model implemented from | -6.01 cm/s |
Lipinski? Lipinski (Pfizer) filter: implemented from | 0.0 |
Ghose? Ghose filter: implemented from | None |
Veber? Veber (GSK) filter: implemented from | 0.0 |
Egan? Egan (Pharmacia) filter: implemented from | 0.0 |
Muegge? Muegge (Bayer) filter: implemented from | 0.0 |
Bioavailability Score? Abbott Bioavailability Score: Probability of F > 10% in rat | 0.55 |
PAINS? Pan Assay Interference Structures: implemented from | 0.0 alert |
Brenk? Structural Alert: implemented from | 1.0 alert: heavy_metal |
Leadlikeness? Leadlikeness: implemented from | No; 1 violation:MW<1.0 |
Synthetic accessibility? Synthetic accessibility score: from 1 (very easy) to 10 (very difficult) | 3.4 |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
41% | With potassium carbonate;tetrakis(triphenylphosphine) palladium(0); In 1,4-dioxane; at 90℃; for 24h;Sonication; | Example 2 Synthesis of 2-Phenoxathiin-4-yl-6-morpholin-4-yl-pyran-4-one (5) 2-Chloro-6-morpholin-4-yl-pyran-4-one (3)(863 mg, 4 mmol), <strong>[100124-07-0]phenoxathiin-4-boronic acid</strong> (1.07 g, 4.4 mmol), and ground potassium carbonate (1.1 g, 8 mmol) were suspended in dioxane (10 ml) and degassed (sonication for 5 minutes then saturated with N2). Pd(PPh3)4 (231 mg, 0.2 mmol) was then added and the reaction mixture was then heated at 90 C. for 24 hours under a vigorous stirring and a N2 atmosphere. The solvent was removed in vacuo and the residue was then suspended in water (50 ml) and extracted with ethyl acetate (3*50 ml). The organics were combined, washed with saturated brine and dried over sodium sulphate. The solvent was removed in vacuo and the residue was purified by column chromatography (silica; ethyl acetate:ethanol; 9:1) to give the title compound as a white solid (620 mg, 41%). 1H-NMR (300 MHz, DMSO-d6): δ=3.38 (4H, t, J 5 Hz); 3.71 (4H, t, J 5 Hz); 5.49 (1H, d, J 2 Hz); 6.49 (1H, d, J 2 Hz); 7.06 (1H, dd, J 1 and 8 Hz); 7.26 (4H, m); 7.46 (1H, dd, J 1.5 and 8 Hz); 7.55 (1H, dd, J 1.5 and 8 Hz). m/z (LC-MS, ESP): 380 (M++1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium carbonate;tetrakis(triphenylphosphine) palladium(0); In ethanol; water; toluene; at 90℃; for 24h; | N,N-Diethyl-4-(4-phenoxathiinyl-4-piperidinylidenemethyl)- benzamide To a mixture of INTERMEDIATE 5 (0.202 g, 0.448 mmol), 4-PHENOXATHIINYL boronic acid (0.164 g, 0.672 MMOL), toluene (3.6 mL), ethanol (0.84 mL), and 2.0 M NA2CO3 (0.56 mL) in a N2 purged vial was added palladium tetrakistriphenylphosphine (0. 0518 g, 0.045 mmol). The resulting mixture was heated at 90 C for 24 h. The reaction was then concentrated in vacuo and the residue was diluted with water (4 mL) and CH2CI2 (4 mL). The layers were separated, and the aqueous phase was extracted with CH2CI2. The combined organic phases were dried over NA2SO4, filtered, and concentrated in vacuo. The crude product was purified by silica gel column chromatography eluting with 5: 1 CH2CI2 : EtOAc. The purified product was dissolved in CH2CI2 (10 mL) and trifluoroacetic acid (1 mL) was added. After 1.5 h, the reaction was concentrated in vacuo. The residue was LYOPHILIZED from CH3CN/H20 to give COMPOUND 3 as its trifluoroacetic acid salt (0.250 g, 95%) as a slightly yellow solid. Purity (HPLC): > 99% ; H NMR (400MHZ, CD30D) 8 1.06 (br t, J = 6.9 Hz, 3H), 1.22 (br t, J = 7.2 Hz, 3H), 2.44-2. 58 (m, 2H), 2.63-2. 73 (m, 1 H), 2.74-2. 83 (m, L H), 3.18-3. 28 (m, 5H), 3.31-3. 40 (m, 1 H), 3.52 (br q, J = 7.4 Hz, 2H), 6.75 (dd, J = 1.3 Hz, 7.9 Hz, IH), 6.98-7. 13 (m, 5H), 7.14-7. 17 (M, 1H), 7. 35 (s, 4H). | |
With sodium carbonate;tetrakis(triphenylphosphine) palladium(0); In ethanol; toluene; at 90℃; for 24h; | To a mixture of INTERMEDIATE 5 (0.202 g, 0.448 MMOL), 4-phenoxathiinyl boronic acid (0.164 g, 0.672 MMOL), toluene (3.6 mL), ethanol (0.84 mL), and 2.0 M NA2CO3 (0.56 mL) in a N2 purged vial was added palladium tetrakistriphenylphosphine (0. 0518 g, 0.045 MMOL). The resulting mixture was heated at 90 C for 24 h. The reaction was then CONCENTRATED IN VACUO and the residue was diluted with water (4 mL) and CH2CI2 (4 mL). The layers were separated, and the aqueous phase was extracted with CH2CI2. The combined organic phases were dried over NA2SO4, filtered, and CONCENTRATED IN VACUO. The crude product was purified by silica gel column chromatography eluting with 5: 1 CH2CI2 : EtOAc. The purified product was dissolved in CH2CI2 (10 mL) and trifluoroacetic acid (I mL) was added. After 1. 5 h, the reaction was CONCENTRATED IN VACUO. The residue was LYOPHILIZED from CH3CN/H20 to give COMPOUND 3 as its trifluoroacetic acid salt (0.250 g, 95%) as a slightly yellow solid. Purity (HPLC) : > 99% ; H NMR (400MHZ, CD30D) 8 1.06 (br t, J = 6.9 Hz, 3H), 1.22 (br t, J = 7.2 Hz, 3H), 2.44-2. 58 (m, 2H), 2.63-2. 73 (M, 1H), 2.74-2. 83 (m, 1 H), 3.18-3. 28 (m, 5H), 3. 31-3. 40 (m, 1H), 3.52 (br q, J = 7.4 Hz, 2H), 6.75 (dd, J = 1. 3 Hz, 7.9 Hz, 1H), 6.98-7. 13 (m, 5H), 7.14-7. 17 (m, 1 H), 7. 35 (s, 4H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
91% | With tetrakis(triphenylphosphine) palladium(0); potassium carbonate; In tetrahydrofuran; water; at 70℃; for 8h;Inert atmosphere; | 4-phenoxathiinyl boronic acid 18.8g (76.88mmol),methyl-2-bromo-5-chloro-benzoate 18.2g (84.57mmol) and tetrakis triphenylphosphinepalladium0.89g (0.769mmol) were placed in a flask, and under a nitrogen atmosphere, itwas dissolved in tetrahydrofuran 257 ml, and then an aqueous solution 128ml of dissolved potassium carbonate 17g (115.3mmol) was added, and stirred at reflux at 70 Cfor 8 h. After completion of the reaction, it was extracted with ethyl acetate,the extract was dried over magnesium sulfate, filtered and the filtrate was concentrated under reduced pressure. The product was purified by silica gel column chromatography using n-hexane / ethyl acetate (9: 1 volume ratio) to obtain intermediate M-22 of the desired compound 23.4 g (91% yield). |
83% | With tetrakis(triphenylphosphine) palladium(0); tetrabutylammomium bromide; potassium carbonate; In water; toluene; at 80℃; for 6h;Inert atmosphere; | 2.7g (11mmol) of phenoxi-4-boronic acid, 2.38g (11mmol) of methyl 2-bromobenzoate, 3.06g (22mmol) of potassium carbonate,A mixture of 0.1278 g (0.1 mmol) of tetrakis (triphenylphosphine) palladium and 0.0357 g (0.1 mmol) of tetrabutylammonium bromide was added to a 100 mL three-necked flask, and a mixed solvent of toluene / water of 20 mL / 10 mL was added to the flask ,After replacing the air in the clean flask with nitrogen, the temperature was raised to 80 C under stirring for 6 hours.The reaction solution was washed with water and dried over anhydrous magnesium sulfate, and the organic phase was distilled under reduced pressure to remove toluene.The obtained solid was recrystallized with ethyl acetate to obtain compound 4-1 (compound4-1) (2.91 g, yield 83%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | With tetrakis(triphenylphosphine) palladium(0); potassium carbonate; In tetrahydrofuran; water; at 70℃; for 8h;Inert atmosphere; | 4 -phenoxathiinyl boronic acid 18.8g (76.88mmol),methyl-2-bromo-5-chloro-benzoate 21.1g (84.57mmol) and tetrakis triphenylphosphinepalladium0.89g (0.769mmol) were placed in a flask, and under a nitrogen atmosphere, itwas dissolved in tetrahydrofuran 257 ml, and then an aqueous solution 128ml of dissolvedpotassium carbonate 17g (115.3mmol) was added, and stirred at reflux at 70 C for 8 h. After completion of the reaction, it was extracted with ethyl acetate,the extract was dried over magnesium sulfate, filtered and the filtrate was concentrated under reduced pressure. The product was purified by silica gelcolumn chromatography using n- hexane / ethyl acetate (9: 1 volume ratio) to obtain intermediate M-3 of the desired compound 26.1 g (92% yield). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
68% | Intermediate 1 (30 g, 145 mmol) was added to 300 mL of tetrahydrofuran (THF) and cooled to -78 C. After that, n-butyllithium (n-BuLi) (72 mL, 180 mmol) was slowly added dropwise over 1 hour while stirring, and the reaction was carried out for 1 hour, followed by raising the temperature to room temperature and reacting for 2 hours. After cooling to -78 C. again, triisopropyl borate (33.8 g, 180 mmol) was slowly charged. After further reaction for 2 hours, the temperature was slowly raised to room temperature and reacted for 4 hours.After the reaction, dilute hydrochloric acid (HCl) was added to terminate the reaction, the aqueous layer and the organic layer were separated, and the organic layer was distilled under reduced pressure and extracted with chloroform (1 L) / water (1 L).The solution was dried over magnesium sulfate, and then the organic layer was distilled under reduced pressure. Hexane was used to manufacture Intermediate 4 (25 g, 68%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
54% | Intermediate 8 (20.0 g, 27 mmol) and Intermediate 4 (6.7 g, 27 mmol) were placed in 200 mL of tetrahydrofuran (THF) under nitrogen atmosphere, stirred and refluxed.After that, potassium carbonate (K2CO3) (7.5 g, 54.5 mmol) was dissolved in 30 mL of water and charged. After sufficiently stirring, tetraphenylphosphine palladium (0.9 g, 0.8 mmol) was charged. After 6 hours of reaction, the temperature was lowered to room temperature and filtered.After the filtrate was extracted with chloroform and water, the organic layer was dried over magnesium sulfate. After that, the organic layer was distilled under reduced pressure and recrystallized with ethyl acetate. The resulting solid was filtered and dried to produce Compound 1 (9.3 g, 54%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
71% | Under a nitrogen atmosphere,Intermediate 8A (20.0 g, 27 mmol) and Intermediate 4 (6.7 g, 27 mmol) manufactured by the same method as the synthesis example of the above Intermediate 8 were added to 200 mL of tetrahydrofuran (THF), and the mixture was stirred and refluxed.After that, potassium carbonate (K2CO3) (7.5 g, 54.5 mmol) was dissolved in 30 mL of water and charged. After sufficiently stirring, tetraphenylphosphine palladium (0.9 g, 0.8 mmol) was charged. After 6 hours of reaction, the temperature was lowered to room temperature and filtered.After the filtrate was extracted with chloroform and water, the organic layer was dried over magnesium sulfate. After that, the organic layer was distilled under reduced pressure and then recrystallized with ethyl acetate. The resulting solid was filtered and dried to produce Compound 4 (12.3 g, 71%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
44% | Under a nitrogen atmosphere,Intermediate 8B manufactured by the same method as the synthesis example of the above intermediate 8 was used(20.0 g, 27 mmol) and Intermediate 4 (6.7 g, 27 mmol) were added to 200 mL of tetrahydrofuran, stirred and refluxed.After that, potassium carbonate (K2CO3) (7.5 g, 54.5 mmol) was dissolved in 30 mL of water and charged. After sufficiently stirring, tetraphenylphosphine palladium (0.9 g, 0.8 mmol) was charged. After 6 hours of reaction, the temperature was lowered to room temperature and filtered.After the filtrate was extracted with chloroform and water, the organic layer was dried over magnesium sulfate. After that, the organic layer was distilled under reduced pressure and then recrystallized with ethyl acetate. The resulting solid was filtered and dried to produce compound 5 (7.6 g, 44%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | With sodium hydrogencarbonate; copper(II) sulfate; In methanol; at 10 - 30℃; for 12h;Inert atmosphere; Sealed tube; | General procedure: Operation steps: Under the condition of argon protection, weigh 0.9mmol boric acid,0.5mmol reagent, 0.05mmol copper sulfate, 0.75mmol sodium bicarbonate,5 mL of methanol was placed in a 25 mL sealed tube and reacted at room temperature for 12 h. After the reaction is over,10 mL of water was added, extracted with anhydrous ether, dried over anhydrous magnesium sulfate, filtered through celite, and concentrated. The residue was subjected to flash silica gel column chromatography to obtain 135 mg of a colorless oily liquid.The yield was 90%. |
Tags: 100124-07-0 synthesis path| 100124-07-0 SDS| 100124-07-0 COA| 100124-07-0 purity| 100124-07-0 application| 100124-07-0 NMR| 100124-07-0 COA| 100124-07-0 structure
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL